Success Metrics

Clinical Success Rate

100.0%

Based on 21 completed trials

Completion Rate

100%(21/21)

Active Trials

8(24%)

Results Posted

67%(14 trials)

Phase Distribution

Ph phase_3

Ph not_applicable

39%

Ph early_phase_1

Ph phase_2

15%

Ph phase_1

12%

Ph phase_4

27%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution33 total trials

Early Phase 1First-in-human

1(3.0%)

Phase 1Safety & dosage

4(12.1%)

Phase 2Efficacy & side effects

5(15.2%)

Phase 3Large-scale testing

1(3.0%)

Phase 4Post-market surveillance

9(27.3%)

N/ANon-phased studies

13(39.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.3%

21 of 23 finished

Non-Completion Rate

8.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(10)

Completed(21)

Terminated(2)

Detailed Status

Completed21

Active, not recruiting7

Withdrawn2

Not yet recruiting1

Enrolling by invitation1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (3.0%)

Phase 14 (12.1%)

Phase 25 (15.2%)

Phase 31 (3.0%)

Phase 49 (27.3%)

N/A13 (39.4%)

Trials by Status

active_not_recruiting721%

not_yet_recruiting13%

enrolling_by_invitation13%

recruiting13%

completed2164%

withdrawn26%

Recent Activity

8 active trials

Showing 5 of 33

not_yet_recruitingphase_3

iCanQuit Smoking Cessation Among Hispanic Adults

NCT06811038

active_not_recruitingnot_applicable

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

NCT05645146

completednot_applicable

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more

NCT06811038Phase 3

iCanQuit Smoking Cessation Among Hispanic Adults

Not Yet Recruiting

NCT05645146Not Applicable

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Active Not Recruiting

NCT05004662Not Applicable

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

Completed

NCT02271919Phase 4

Varenicline and Combined NRT for Smoking Cessation

Active Not Recruiting

NCT05014282Not Applicable

Automated Video-Assisted Smoking Treatment for People Living With HIV

Active Not Recruiting

NCT03315910Phase 4

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Active Not Recruiting

NCT06161675Not Applicable

Feasibility of Delivering VergeRx at FQHCs

Active Not Recruiting

NCT05351606Phase 4

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya

Completed

NCT06763536Not Applicable

Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia

Recruiting

NCT03720899Phase 2

Comparing NicoBloc to Nicotine Lozenges

Completed

NCT05206435Phase 4

Methadone-Maintained Smokers Switching to E-Cigarettes

Active Not Recruiting

NCT05290025Not Applicable

Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco

Active Not Recruiting

NCT05627596Phase 2

Free Samples for Health

Enrolling By Invitation

NCT05060965Early Phase 1

Inpatient Smoking Cessation Pilot Program

Withdrawn

NCT02157610Not Applicable

Smoking Cessation for Cervical Cancer Survivors

Completed

NCT03822416Phase 2

Treating Smokers With Mental Illness

Completed

NCT03069482Phase 1

Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness

Completed

NCT01553084Phase 4

A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers

Completed

NCT02513069Not Applicable

Mobile Contingency Management for Smoking Cessation in Returning US Veterans

Completed

NCT02869451Not Applicable

Mobile Contingency Management for Marijuana and Tobacco Cessation

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 33